July 27, 2017 11:08 AM ET

Life Sciences Tools and Services

Company Overview of Provid Pharmaceuticals, Inc.

Key Executives for Provid Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gary L. Olson Ph.D.12 RelationshipsChief Executive Officer, President, Chief Scientific Officer and Director--
Edwin J. Thomas 12 RelationshipsChief Financial Officer and Director--
Richard H. Christie M.D., Ph.D.No RelationshipsVice President of Business Development--
Christopher R. Self Ph.D.12 RelationshipsVice President of Medicinal Chemistry and Director--

Provid Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Wolfgang Oster M.D., Ph.D. 43 RelationshipsOncoceutics, Inc.59
Gary L. Olson Ph.D. 12 RelationshipsProvid Pharmaceuticals, Inc.--
Edwin J. Thomas 12 RelationshipsProvid Pharmaceuticals, Inc.--
Christopher R. Self Ph.D. 12 RelationshipsProvid Pharmaceuticals, Inc.--
Warren J. Strittmatter M.D. 29 RelationshipsProvid Pharmaceuticals, Inc.--
View All Board Members

Provid Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
421.9K
Bonus
273.3K
Total Short Term Compensation
506.4K
Total Value of Options
21.7M
Compensation as of Fiscal Year
Provid Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Guangzhou Boji Medical & Biotechnological Co., Ltd. Announces Executive Appointments
July 26, 2017 3:32 PM ET
Adaptive Biotechnologies Announces Management Changes
July 26, 2017 12:30 PM ET
QuintilesIMS Appointments Colleen Goggins to its Board of Directors
July 26, 2017 1:01 AM ET
Venn Life Sciences Appoints Christian Bernard Milla as Chief Operating Officer, Effect from August 16, 2017
July 25, 2017 6:00 AM ET
Oncosil Medical Limited Announces Resignation of Peter Casey as Company Secretary
July 24, 2017 11:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Provid Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.